To explore whether the protective effect of SLAMF8 inhibition on APS pathogenesis is associated with reduced inflammation and thrombosis, we compared the levels of inflammatory and thrombotic indicators in SLAMF8‐OE and SLAMF8‐knockdown THP‐1 cells. Here, SLAMF8 is linked to autoimmune polyendocrinopathy.